ATE244562T1 - In-situ-erzeugung von polymermaterial - Google Patents

In-situ-erzeugung von polymermaterial

Info

Publication number
ATE244562T1
ATE244562T1 AT98938785T AT98938785T ATE244562T1 AT E244562 T1 ATE244562 T1 AT E244562T1 AT 98938785 T AT98938785 T AT 98938785T AT 98938785 T AT98938785 T AT 98938785T AT E244562 T1 ATE244562 T1 AT E244562T1
Authority
AT
Austria
Prior art keywords
polymer material
situ generation
situ
generation
polymer
Prior art date
Application number
AT98938785T
Other languages
English (en)
Inventor
Peter William Dettmar
Ian Gordon Jolliffe
Oyvind Skaugrud
Original Assignee
Reckitt Benckiser Healthcare
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9717627.5A external-priority patent/GB9717627D0/en
Priority claimed from GBGB9717626.7A external-priority patent/GB9717626D0/en
Application filed by Reckitt Benckiser Healthcare filed Critical Reckitt Benckiser Healthcare
Application granted granted Critical
Publication of ATE244562T1 publication Critical patent/ATE244562T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0076—Sprayable compositions
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
    • C08J3/246—Intercrosslinking of at least two polymers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/04—Alginic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D105/00—Coating compositions based on polysaccharides or on their derivatives, not provided for in groups C09D101/00 or C09D103/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Wood Science & Technology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coating Of Shaped Articles Made Of Macromolecular Substances (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
AT98938785T 1997-08-21 1998-08-10 In-situ-erzeugung von polymermaterial ATE244562T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9717627.5A GB9717627D0 (en) 1997-08-21 1997-08-21 Organic compositions
GBGB9717626.7A GB9717626D0 (en) 1997-08-21 1997-08-21 Organic compositions
PCT/GB1998/002410 WO1999009962A1 (en) 1997-08-21 1998-08-10 In situ formation of polymeric material

Publications (1)

Publication Number Publication Date
ATE244562T1 true ATE244562T1 (de) 2003-07-15

Family

ID=26312097

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98938785T ATE244562T1 (de) 1997-08-21 1998-08-10 In-situ-erzeugung von polymermaterial

Country Status (16)

Country Link
US (1) US6391294B1 (de)
EP (1) EP1007015B1 (de)
JP (1) JP2001513549A (de)
KR (1) KR20010023065A (de)
CN (1) CN1267216A (de)
AR (1) AR016850A1 (de)
AT (1) ATE244562T1 (de)
AU (1) AU737714B2 (de)
BR (1) BR9811245A (de)
CA (1) CA2301165C (de)
DE (1) DE69816307T2 (de)
ES (1) ES2198062T3 (de)
GB (1) GB2328443B (de)
HU (1) HUP0003602A2 (de)
PL (1) PL192463B1 (de)
WO (1) WO1999009962A1 (de)

Families Citing this family (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
US6596298B2 (en) * 1998-09-25 2003-07-22 Warner-Lambert Company Fast dissolving orally comsumable films
AU5926800A (en) * 1999-07-08 2001-01-30 Nanocell, Inc. Semiconductor devices and process for manufacture
US8015677B2 (en) * 2000-12-01 2011-09-13 Aard-Balm Limited Embalming fluid
US8900498B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for manufacturing a resulting multi-layer pharmaceutical film
US20070281003A1 (en) 2001-10-12 2007-12-06 Fuisz Richard C Polymer-Based Films and Drug Delivery Systems Made Therefrom
US8900497B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for making a film having a substantially uniform distribution of components
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
FR2832311B1 (fr) * 2001-11-21 2004-04-16 Besins Int Belgique Poudre filmogene, compositions la comprenant, leurs procedes de preparation et leurs utilisations
DE60327752D1 (de) 2002-03-14 2009-07-09 Medrx Co Ltd Topisches medikament für wunden
US7666876B2 (en) * 2002-03-19 2010-02-23 Vernalis (R&D) Limited Buprenorphine formulations for intranasal delivery
US7241453B2 (en) * 2002-04-05 2007-07-10 Long Island University Antimicrobial surfaces
US7846141B2 (en) 2002-09-03 2010-12-07 Bluesky Medical Group Incorporated Reduced pressure treatment system
US7714011B2 (en) * 2002-09-13 2010-05-11 Zicam, Llc Compositions to reduce congestion and methods for application thereof to the nasal membrane
US20040057907A1 (en) * 2002-09-23 2004-03-25 Leonard Mackles Dri-nasal sprays
GB0224986D0 (en) 2002-10-28 2002-12-04 Smith & Nephew Apparatus
US9561182B2 (en) * 2003-08-22 2017-02-07 Cure Pharmaceutical Corporation Edible films for administration of medicaments to animals, methods for their manufacture and methods for their use for the treatment of animals
US8999372B2 (en) * 2002-11-14 2015-04-07 Cure Pharmaceutical Corporation Methods for modulating dissolution, bioavailability, bioequivalence and drug delivery profile of thin film drug delivery systems, controlled-release thin film dosage formats, and methods for their manufacture and use
US20040136923A1 (en) * 2002-11-14 2004-07-15 Davidson R Steven Edible film for relief of cough or symptoms associated with pharyngitis
US20040131662A1 (en) * 2003-11-12 2004-07-08 Davidson Robert S. Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films
US20040191302A1 (en) 2003-03-28 2004-09-30 Davidson Robert S. Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films
GB0300531D0 (en) 2003-01-10 2003-02-12 West Pharm Serv Drug Res Ltd Pharmaceutical compositions
GB2398496A (en) * 2003-02-20 2004-08-25 Reckitt Benckiser Healthcare Suspensions of water-swellable polymer particles which are substantially water-free or contain insufficient water to fully swell the particles
US20040185119A1 (en) * 2003-02-26 2004-09-23 Theuer Richard C. Method and compositions for treating gastric hyperacidity while diminishing the likelihood of producing vitamin deficiency
US7909805B2 (en) 2004-04-05 2011-03-22 Bluesky Medical Group Incorporated Flexible reduced pressure treatment appliance
US10058642B2 (en) 2004-04-05 2018-08-28 Bluesky Medical Group Incorporated Reduced pressure treatment system
US8062272B2 (en) 2004-05-21 2011-11-22 Bluesky Medical Group Incorporated Flexible reduced pressure treatment appliance
GB0409446D0 (en) 2004-04-28 2004-06-02 Smith & Nephew Apparatus
WO2006031420A2 (en) * 2004-08-27 2006-03-23 Spherics, Inc. Multi-layer tablets and bioadhesive dosage forms
WO2006026504A2 (en) * 2004-08-27 2006-03-09 Spherics, Inc. Mucoadhesive oral formulations of high permeability, high solubility drugs
US20080311191A1 (en) * 2004-08-27 2008-12-18 Avinash Nangia Multi-Layer Tablets and Bioadhesive Dosage Forms
CN101351196B (zh) * 2005-10-26 2013-07-03 班纳制药公司 作为胶囊填充物的基于亲脂性载体的双重控释基质系统
US8123849B2 (en) * 2005-11-29 2012-02-28 Ideal Cures Pvt. Ltd. Aqueous film coating composition containing sodium alginate and preparation thereof
EP1810669A1 (de) * 2006-01-19 2007-07-25 Holger Lars Hermann Darreichungsform für Buprenorphin
CA2636582A1 (en) * 2006-01-20 2007-07-26 Monosol Rx, Llc Film bandage for mucosal administration of actives
WO2007086078A2 (en) * 2006-01-30 2007-08-02 Panacea Biotec Ltd. Novel pharmaceutical compositions and process of preparation thereof
EP1897543A1 (de) * 2006-08-30 2008-03-12 Euro-Celtique S.A. Buprenorphine-Waffel zur Substitutionstherapie
GB0707758D0 (en) * 2007-04-21 2007-05-30 Smith & Nephew A foam material for medical use and method for producing same
GB0722820D0 (en) 2007-11-21 2008-01-02 Smith & Nephew Vacuum assisted wound dressing
WO2009067605A2 (en) * 2007-11-21 2009-05-28 The Procter & Gamble Company Preparations, methods and kits useful for treatment of cough
CN104382691B (zh) 2007-11-21 2018-08-31 史密夫及内修公开有限公司 伤口包敷物
WO2009067711A2 (en) 2007-11-21 2009-05-28 T.J. Smith & Nephew, Limited Suction device and dressing
US11253399B2 (en) 2007-12-06 2022-02-22 Smith & Nephew Plc Wound filling apparatuses and methods
GB0723875D0 (en) 2007-12-06 2008-01-16 Smith & Nephew Wound management
US20130096518A1 (en) 2007-12-06 2013-04-18 Smith & Nephew Plc Wound filling apparatuses and methods
US20090145433A1 (en) * 2007-12-08 2009-06-11 Michael James Apparatus for dispensing a powdered composition into the aerodigestive tract
US20090148530A1 (en) * 2007-12-08 2009-06-11 Jamie Koufman Method for prevention and treatment of reflux injury in the aerodigestive tract and laryngopharynx caused by pepsin
GB0803564D0 (en) 2008-02-27 2008-04-02 Smith & Nephew Fluid collection
US8298200B2 (en) 2009-06-01 2012-10-30 Tyco Healthcare Group Lp System for providing continual drainage in negative pressure wound therapy
US8298198B2 (en) 2008-04-21 2012-10-30 Mcneil-Ppc, Inc. Dual spray can topical delivery device
EP2291514B1 (de) * 2008-05-22 2020-12-23 Vesta Therapeutics, Inc. Verfahren zur differenzierung von säugervorläuferzellen zu insulinproduzierenden pankreas-inselzellen
GB0902816D0 (en) 2009-02-19 2009-04-08 Smith & Nephew Fluid communication path
EP2515961B1 (de) 2009-12-22 2019-04-17 Smith & Nephew, Inc. Vorrichtungen für unterdruckwundtherapie
US9974693B2 (en) * 2010-01-22 2018-05-22 Kci Licensing, Inc. Devices, systems, and methods for instillation of foamed fluid with negative pressure wound therapy
US9061095B2 (en) 2010-04-27 2015-06-23 Smith & Nephew Plc Wound dressing and method of use
USRE48117E1 (en) 2010-05-07 2020-07-28 Smith & Nephew, Inc. Apparatuses and methods for negative pressure wound therapy
GB201011173D0 (en) 2010-07-02 2010-08-18 Smith & Nephew Provision of wound filler
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
GB201020005D0 (en) 2010-11-25 2011-01-12 Smith & Nephew Composition 1-1
CN107033596A (zh) 2010-11-25 2017-08-11 史密夫及内修公开有限公司 组合物i – ii及其产品和用途
RU2016111981A (ru) 2010-12-22 2018-11-27 Смит Энд Нефью, Инк. Устройство и способ лечения ран отрицательным давлением
EP2527053A1 (de) 2011-05-24 2012-11-28 Siemens Aktiengesellschaft Steuerverfahren für eine Walzstraße
DE102011077063A1 (de) * 2011-06-07 2012-12-13 Beiersdorf Ag Wirkstoffkombinationen aus å-Polylysin (Epsilon-Polylysin) und einem oder mehrerenaromatischen Alkoholen
SG10201610469QA (en) 2011-11-13 2017-02-27 Cresilon Inc In-situ cross-linkable polymeric compositions and methods thereof
US20150159066A1 (en) 2011-11-25 2015-06-11 Smith & Nephew Plc Composition, apparatus, kit and method and uses thereof
DE202011109558U1 (de) * 2011-12-09 2012-12-12 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung für die topische Anwendung bei entzündlichen Erkrankungen der Haut und/oder Schleimhaut
EP2968647B1 (de) 2013-03-15 2022-06-29 Smith & Nephew plc Wundverbanddichtmasse und verwendung davon
US10716802B2 (en) 2013-03-15 2020-07-21 The Brigham And Women's Hospital, Inc. Compounds to modulate intestinal absorption of nutrients
US20160120706A1 (en) 2013-03-15 2016-05-05 Smith & Nephew Plc Wound dressing sealant and use thereof
TWI482632B (zh) * 2013-06-04 2015-05-01 Ming Jium Shieh 醫藥用載體及使用該載體的藥物結構
AU2014369916A1 (en) 2013-12-24 2016-06-16 Durect Corporation Uses of oxygenated cholesterol sulfates (OCS)
EP2716282A1 (de) * 2014-01-09 2014-04-09 College of Pharmacy of Taif University Pharmazeutische Zusammensetzung mit kontrollierter Freisetzung
KR20160141607A (ko) 2015-06-01 2016-12-09 주식회사 성균관생활건강 커큐민이 코팅된 초콜릿 가공품 및 이의 제조방법
JP2018522101A (ja) 2015-06-22 2018-08-09 クレシロン， インコーポレイテッド 高度に有用な止血用接着性ポリマー足場
WO2017053970A1 (en) 2015-09-24 2017-03-30 The Brigham And Women's Hospital, Inc. Water-activated mucoadhesive compositions to reduce intestinal absorption of nutrients
US12433850B2 (en) 2016-05-05 2025-10-07 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine and prodrug compositions
JP7653218B2 (ja) 2016-05-05 2025-03-28 アクエスティブ セラピューティクス インコーポレイテッド 送達増強エピネフリン組成物
US12427121B2 (en) 2016-05-05 2025-09-30 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine compositions
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
US10675365B2 (en) 2016-09-29 2020-06-09 Korea Atomic Energy Research Institute Curcumin derivative, method for producing same, and photo-acoustic imaging agent comprising same for detecting beta-amyloid plaque
TR201713929A2 (tr) * 2017-09-20 2019-04-22 Montero Gida Sanayi Ve Ticaret Anonim Sirketi Ki̇tosan ve alji̇natin hemostati̇k kompozi̇syonlari
GB201811449D0 (en) 2018-07-12 2018-08-29 Smith & Nephew Apparatuses and methods for negative pressure wound therapy
GB202000574D0 (en) 2020-01-15 2020-02-26 Smith & Nephew Fluidic connectors for negative pressure wound therapy
MX2024000361A (es) * 2021-07-05 2024-04-16 Reflux Gourmet Llc Metodo para neutralizar el ácido del estómago utilizando alginato, polilisina y conservantes de semillas.
US12465564B2 (en) 2021-10-25 2025-11-11 Aquestive Therapeutics, Inc. Oral and nasal compositions and methods of treatment

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2194144B (en) 1986-08-22 1990-04-25 American Cyanamid Co Stable pharmaceutical gel preparation
JPS57106611A (en) * 1980-12-22 1982-07-02 Sanwa Kagaku Kenkyusho:Kk Coating remedy
US4501835A (en) 1982-03-08 1985-02-26 Polaroid Corporation Polyacrylic acid/chitosan polyelectrolyte complex
JPS5974984A (ja) * 1982-10-21 1984-04-27 Sumitomo Chem Co Ltd 固定化酵素もしくは固定化微生物の製造方法
EP0159604B1 (de) 1984-04-09 1990-11-07 Toyo Boseki Kabushiki Kaisha Präparat mit verzögerter Freigabe zum Aufbringen auf die Schleimhäute der Mundhöhle
US4996150A (en) * 1984-10-29 1991-02-26 Amoco Corporation Biocatalyst immobilization in a gel of anionic polysaccharide and cationic polymer
DE3686275T2 (de) * 1985-01-11 1993-03-18 Teijin Ltd Praeparate mit verzoegerter freisetzung.
US4913743A (en) * 1987-04-15 1990-04-03 Biomatrix, Inc. Processes for managing keratinous material using glycosaminoglycan and cationic polymer combinations
DE3827561C1 (de) * 1988-08-13 1989-12-28 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
AU9115791A (en) * 1990-11-30 1992-06-25 Baker Cummins Dermatologicals, Inc. Skin protective compositions and method of inhibiting skin irritation
GB9026244D0 (en) * 1990-12-03 1991-01-16 Ghali Ragui L Granular liquid absorbents
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
EP0544259A1 (de) * 1991-11-27 1993-06-02 Lignyte Co., Ltd. Wasserlöslicher biokompatibler Hyaluron- und Polyionen-Komplex und Herstellungsverfahren
DE69218555T2 (de) 1991-11-28 1997-08-21 Canon Kk Vorrichtung und Verfahren zur Herstellung eines Substrates für Informationsträger
US5380522A (en) * 1992-08-11 1995-01-10 Day; Charles E. Method for treatment of irritable bowel syndrome
FI95207C (fi) 1992-09-14 1996-01-10 Novasso Oy Haavansuojaside
GB2275686B (en) * 1993-03-03 1997-04-30 Johnson & Johnson Medical Swellable wound dressing materials
IT1273742B (it) * 1994-08-01 1997-07-09 Lifegroup Spa Composizioni ad elevata bioadesivita' e mucoadesivita' utili per il trattamento di epitali e mucose
PT876165E (pt) * 1995-12-18 2006-10-31 Angiotech Biomaterials Corp Composicoes de polimeros reticulados e processos para a sua utilizacao

Also Published As

Publication number Publication date
DE69816307D1 (de) 2003-08-14
ES2198062T3 (es) 2004-01-16
JP2001513549A (ja) 2001-09-04
PL338701A1 (en) 2000-11-20
AR016850A1 (es) 2001-08-01
DE69816307T2 (de) 2004-05-27
CA2301165C (en) 2007-01-09
PL192463B1 (pl) 2006-10-31
GB9817093D0 (en) 1998-10-07
GB2328443B (en) 2001-09-05
EP1007015A1 (de) 2000-06-14
BR9811245A (pt) 2000-07-18
AU737714B2 (en) 2001-08-30
CN1267216A (zh) 2000-09-20
US6391294B1 (en) 2002-05-21
KR20010023065A (ko) 2001-03-26
AU8738998A (en) 1999-03-16
CA2301165A1 (en) 1999-03-04
GB2328443A (en) 1999-02-24
EP1007015B1 (de) 2003-07-09
WO1999009962A1 (en) 1999-03-04
HUP0003602A2 (en) 2001-03-28

Similar Documents

Publication Publication Date Title
DE69816307D1 (de) In-situ-erzeugung von polymermaterial
DE69802670D1 (de) Flash-gesponnenes flächiges material
NO20002470D0 (no) Ny materialsammensetning
ID24176A (id) Bahan pembantu sementasi
DE69739738D1 (de) Epoxy-Polysiloxan-Polymer-Zusammensetzung
DE69830013D1 (de) Programmerzeugung
NO982300D0 (no) Polymermateriale
NO20001938D0 (no) Nye aryloksy-alkyl-dialkylaminer
FI20000371L (fi) Aineen prosessointi
NO996435D0 (no) Polymerisasjonsprosess
NO20000014D0 (no) Grohemmende polymerer
ID20789A (id) Zat pemutih fluoresen
FI971338A0 (fi) Muovipohjainen materiaali
DE69735938D1 (de) Oberflächenmodifiziertes fluorokautschukdichtungsmaterial
DE69833186D1 (de) Nanoverbundmaterial von dendritischen polymeren
DE69834448D1 (de) Kontaktwerkstoffe
FI972210A0 (fi) Icke-svettdrivande material
ID23979A (id) Polimer polieter-aminosiloksana
FI974634A0 (fi) Anordning foer matning av material
NO20003168L (no) Polymerisasjonsmetode
NO993662D0 (no) Polymerer
NO993432D0 (no) Polymerisasjonsprosess
DE69812129D1 (de) Gelmaterialien
DE59813503D1 (de) Elektrodenmaterial
FI972381A0 (fi) Foerfarande foer framstaellning av kopolymerer foer antistatiska polymer belaeggningar

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties